Overview
MRC AIM is a Doctoral Training Programme (DTP) funded by the MRC between three academic partners – Universities of Birmingham, Leicester, and Nottingham.
The research projects that PhD students within AIM undertake use cutting-edge, inter-disciplinary research methods to create and interrogate innovative models of disease. As part of the partnership, AIM PhD students work with complex data, cell-based models, model organisms and patients to better understand areas of clinical need such as metabolic and infectious diseases, cancer, chronic inflammatory conditions and respiratory disease, and psychological disorders.
University of Leicester projects for September 2025 are listed below and also on the AIM website.
Training
Available training is likely to include the following although this is not a comprehensive list and is subject to change:
- Communicating science to diverse audiences
- Scientific writing
- Industry networking sessions
- Careers beyond academia sessions
- Good research practice, reproducibility and FAIR data use
- Ethics in research
- Advanced research taster sessions
- Statistics and quantitative methods in research
- Mental health awareness and resilience
- Coping with unpredictability in research
- Team-building and leadership
Industrial partners
A PhD opens the door for a range of research-related careers in both academic and industry settings. The DTP offers PhD projects that are co-led by academic/industry collaborations (iCASE studentships) as well as opportunities for students to undertake placements that give them a taste of working in the biomedical industry sector. We have a close relationship with two pharmaceutical companies, AstraZeneca and UCBPharma, who will provide all DTP students with valuable knowledge and insight into the sector, as well as ensuring that our comprehensive training programme equips our students with the necessary skills for a career outside of academia.